Liver Damage in the Context of SARS-CoV-2. Covid-19 Treatment and Its Effects on the Liver

Overview

Journal J Med Life

Specialty General Medicine

Date 2022 Aug 5

PMID 35928369

Authors

Denisa Marilena Sabiescu

Adina Maria Kamal

Constantin Kamal Kamal

Dragos Ovidiu Alexandru

Paul Mitrut

Affiliations

Soon will be listed here.

Abstract

Since COVID-19 was declared a pandemic by the World Health Organization, the scientific community has tried to protect the population from the infection and its effects through multiple lines of evidence. Patients at high risk of developing severe disease were advised to protect themselves and practice effective physical distancing. Phenotypes specific to this infection need to be reviewed to understand COVID-19 and its clinical manifestations. When the pandemic began, the scientific community was concerned with the unfavorable outcome of cases with pre-existing liver disease. There have been speculations about risk factors for severe diseases such as liver disease, age, gender, and association with obesity or diabetes.

Citing Articles

Before Acute Liver Failure is Attributed to High Altitude, Other Causes Must be Ruled Out.

Finsterer J Indian J Crit Care Med. 2025; 28(12):1180.

PMID: 39759790 PMC: 11695879. DOI: 10.5005/jp-journals-10071-24843.

Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2.

Duloquin G, Pommier T, Georges M, Giroud M, Guenancia C, Bejot Y J Clin Med. 2024; 13(5).

PMID: 38592697 PMC: 10932259. DOI: 10.3390/jcm13051397.

Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients.

Papa A, Covino M, De Lucia S, Del Gaudio A, Fiorani M, Polito G World J Gastroenterol. 2023; 29(26):4099-4119.

PMID: 37475841 PMC: 10354572. DOI: 10.3748/wjg.v29.i26.4099.

Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies.

Khullar N, Bhatti J, Singh S, Thukral B, Reddy P, Bhatti G World J Gastroenterol. 2023; 29(14):2064-2077.

PMID: 37122601 PMC: 10130970. DOI: 10.3748/wjg.v29.i14.2064.

References

Cichoz-Lach H, Michalak A . Liver injury in the era of COVID-19. World J Gastroenterol. 2021; 27(5):377-390. PMC: 7856845. DOI: 10.3748/wjg.v27.i5.377. View

Bertolini A, Van de Peppel I, Bodewes F, Moshage H, Fantin A, Farinati F . Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology. 2020; 72(5):1864-1872. PMC: 7404414. DOI: 10.1002/hep.31480. View

Chua R, Lukassen S, Trump S, Hennig B, Wendisch D, Pott F . COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020; 38(8):970-979. DOI: 10.1038/s41587-020-0602-4. View

Lee W . Acute liver failure in the United States. Semin Liver Dis. 2003; 23(3):217-26. DOI: 10.1055/s-2003-42641. View

Smadja D, Mentzer S, Fontenay M, Laffan M, Ackermann M, Helms J . COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021; 24(4):755-788. PMC: 8238037. DOI: 10.1007/s10456-021-09805-6. View

Muhovic D, Bojovic J, Bulatovic A, Vukcevic B, Ratkovic M, Lazovic R . First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19. Liver Int. 2020; 40(8):1901-1905. PMC: 7276916. DOI: 10.1111/liv.14516. View

Aziz M, Fatima R, Lee-Smith W, Assaly R . The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020; 24(1):255. PMC: 7249975. DOI: 10.1186/s13054-020-02995-3. View

Scagnolari C, Bitossi C, Viscido A, Frasca F, Oliveto G, Scordio M . ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?. Cytokine. 2021; 140:155430. PMC: 7810030. DOI: 10.1016/j.cyto.2021.155430. View

Ma-Lauer Y, Carbajo-Lozoya J, Hein M, Muller M, Deng W, Lei J . p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A. 2016; 113(35):E5192-201. PMC: 5024628. DOI: 10.1073/pnas.1603435113. View

10.

Herath C, Warner F, Lubel J, Dean R, Jia Z, Lew R . Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol. 2007; 47(3):387-95. PMC: 7114685. DOI: 10.1016/j.jhep.2007.03.008. View

11.

Pan H, Peto R, Henao-Restrepo A, Preziosi M, Sathiyamoorthy V, Abdool Karim Q . Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2020; 384(6):497-511. PMC: 7727327. DOI: 10.1056/NEJMoa2023184. View

12.

Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

13.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

14.

Youssef M, Hussein M, Attia A, Elshazli R, Omar M, Zora G . COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies. J Med Virol. 2020; 92(10):1825-1833. PMC: 7283797. DOI: 10.1002/jmv.26055. View

15.

Montastruc F, Thuriot S, Durrieu G . Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019. Clin Gastroenterol Hepatol. 2020; 18(12):2835-2836. PMC: 7381904. DOI: 10.1016/j.cgh.2020.07.050. View

16.

Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L . SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020; 73(4):807-816. PMC: 7211738. DOI: 10.1016/j.jhep.2020.05.002. View

17.

Rauber C, Tiwari-Heckler S, Pfeiffenberger J, Mehrabi A, Lund F, Gath P . SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study. Transplant Proc. 2021; 53(4):1112-1117. PMC: 7831557. DOI: 10.1016/j.transproceed.2020.11.009. View

18.

Huang X, Wei F, Hu L, Wen L, Chen K . Epidemiology and Clinical Characteristics of COVID-19. Arch Iran Med. 2020; 23(4):268-271. DOI: 10.34172/aim.2020.09. View

19.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

20.

Lagana S, Kudose S, Iuga A, Lee M, Fazlollahi L, Remotti H . Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol. 2020; 33(11):2147-2155. PMC: 7424245. DOI: 10.1038/s41379-020-00649-x. View